Clinical parameters for predicting possibility of insulin therapy withdrawal in patients with type 2 diabetes mellitus

Journal of the Japan Diabetes Society

Volumn 47, Issue 4, 2004, Pages 271-275

  Kanda, Yukiko ^a   Yamada, Kayo ^a   Harada, Yumiko ^a   Kawasaki, Fumiko ^a   Saito, Mieko ^a   Inoue, Hiroshi ^a   Matsuda, Masafumi ^a   Matsuki, Michihiro ^a   Etou, Masaaki ^a   Kaku, Kohei ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; C PEPTIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; SULFONYLUREA DERIVATIVE;

ADULT; AGE; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL LABORATORY; CLINICAL OBSERVATION; CLINICAL TRIAL; DIABETES CONTROL; DIET RESTRICTION; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; GLUCOSE HOMEOSTASIS; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOREACTIVITY; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PROTEIN URINE LEVEL;

EID: 2442663848     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. The Diabetes Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progressive of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
2. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of patient with type diabetes (UKPDS 33). Lancet 352: 837-853
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanease patients with non-insulin-dependent diabetes mellitus a randomized prospective 6-year study. Dibetes Res Clin Pract 28: 103-117
4. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22: 920-924
5. DECODE study group (1999) Glucose tolerance and mortality; comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621
6. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44: 249-256
7. UK Prospective Diabetes Study Group (1995) UK Prospective Diabetes Study 16 Overview of 6 years' therapy of type 2 diabetes: a progressive disease. Diabetes 44: 1249-1258
8. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Usellini L, Nano R, Bonini P, Bertuzzi P, Marlier L, Davalli AM, Carandente O, Pontioroli AE, Melino G, Marcetti P, Lauro R, Sesti G, Folli F (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans. Diabetes 50: 1290-1301
9. Kaku K, Kawasaki F, Kanda Y, Matsuda M (in press) Retained capacity of glucose-mediated insulin secretion in patients with type 2 diabetes mellitus inversely correlates with the duration of diabetes. Diab Res Clin Pract